Overview

Economic Impact of Switching From Metoprolol to Nebivolol for Hypertension Treatment

Status:
Unknown status
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
This is a retrospective data analysis of patients with high blood pressure (hypertension) who took metoprolol for a minimum of 6 months who then switched to taking nebivolol for a minimum of 6 month to treat hypertension. These patients will be identified from a large medical claims database. This study tests the hypothesis (alternative, higher or lower) that average patient monthly health care administrative cost changes after switching from metoprolol to nebivolol.
Details
Lead Sponsor:
Forest Laboratories
Treatments:
Metoprolol
Nebivolol